Drugs & Targets FDA approves Fyarro for malignant perivascular epithelioid cell tumor December 03, 2021Vol.47 No.44
Drugs & Targets FDA approves Darzalex Faspro, Kyprolis, and Dexamethasone for multiple myeloma December 03, 2021Vol.47 No.44
Drugs & Targets FDA approves Cytalux for identifying malignant ovarian cancer lesions December 03, 2021Vol.47 No.44
Drugs & Targets FDA grants orphan drug designation to UV1 cancer vaccine in metastatic melanoma December 03, 2021Vol.47 No.44
Drugs & Targets European Commission approves Keytruda plus Lenvima for patients with certain types of endometrial carcinoma December 03, 2021Vol.47 No.44
Drugs & Targets FDA approves Keytruda as adjuvant therapy for patients with RCC following nephrectomy November 19, 2021Vol.47 No.43
Drugs & Targets WVU gets FDA approval for clinical trial of drug to treat eye cancer ‘from the inside out’ November 19, 2021Vol.47 No.43
Drugs & Targets Ribonexus, Pierre Fabre sign licensing agreement on small molecules targeting eIF4A November 19, 2021Vol.47 No.43
Drugs & Targets FDA’s new web pages track accelerated approvals in oncology October 29, 2021Vol.47 No.40
